Hinge Health Inc. Class A Common Stock vs Quanta Services Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Quanta Services Inc trades at $656.72 (market cap $103.57B). The key difference: Quanta Services Inc is far larger — about 12.2× Hinge Health Inc. Class A Common Stock's market cap, and Quanta Services Inc pays a 0.06% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Quanta Services Inc for 62 Days on average.
| HNGE | PWR | |
|---|---|---|
Market Cap | $8.48B | $103.57B |
Volume | 879,799 | 1,036,513 |
Sector | Health | Industrials |
52-Week High | $105.14 | $785.24 |
52-Week Low | $31.17 | $412.21 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $8.10B | $109.67B |
Dividend Yield | — | 0.06% |
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
PWR trades at $660.53, down 4.93% for the day, but maintains strong analyst support with 27 buy ratings and a $802.08 consensus price target. The company has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $4.24 surpassing expectations by 28%. Technical indicators show a bullish trend with support at $682 and resistance at $706. Revenue growth remains robust, climbing from $17.1B in 2022 to $28.5B in 2025.
PWR presents a compelling growth story with strong earnings momentum and a record $53B backlog supporting future revenue. However, elevated valuation ratios (P/E 78.82, EV/EBITDA 35.6) and negative cash flow trends pose risks. The stock offers 21% upside to consensus targets, but investors should weigh premium valuation against execution risks in large infrastructure projects.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →